Delivery Order SPE2DB22D1106-SPE2DB25FEES9
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,349.84, is a delivery order for the supply of 4,568,105,478 units of Terbinafine HCL 250 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract, with a ceiling value of $92,164.85, is for the delivery of terbinafine hydrochloride 250 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,971.41 firm fixed-price delivery order is for the supply of 4,568,188,746 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $8,773.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,187,358 units of the prescription medication Terbinafine HCL 250 mg tablets, with a final completion date of May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract....
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG0NT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,426.98 firm fixed-price delivery order is for the supply of 4,567,967,313 tablets of Terbinafine HCL 250 mg, a medication used to treat fungal infections. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This award is not associated with a set-aside program....
This federal contract award is for the delivery of Terbinafine Hydrochloride 250 mg Tablets in quantities of 30 tablets per package. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,898.46 and an ultimate completion date of November 25, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVL96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,837.26 firm fixed-price delivery order is for the supply of 4,568,078,153 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. This award is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,186.62, is a delivery order for the supply of 4,567,039,299 units of Terbinafine HCL 250 mg tablets. The contract has a firm fixed price and an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $5,556.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,175,171 units of the medication terbinafine HCL 250 mg tablets, with a completion date of May 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX,...
This federal contract award, valued at $7,360.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of terbinafine hydrochloride 250 mg tablets, a medication used to treat fungal infections. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...